Literature DB >> 28005634

The Role of Esophageal Hypersensitivity in Functional Esophageal Disorders.

Adam D Farmer1, James K Ruffle, Qasim Aziz.   

Abstract

The Rome IV diagnostic criteria delineates 5 functional esophageal disorders which include functional chest pain, functional heartburn, reflux hypersensitivity, globus, and functional dysphagia. These are a heterogenous group of disorders which, despite having characteristic symptom profiles attributable to esophageal pathology, fail to demonstrate any structural, motility or inflammatory abnormalities on standard clinical testing. These disorders are associated with a marked reduction in patient quality of life, not least considerable healthcare resources. Furthermore, the pathophysiology of these disorders is incompletely understood. In this narrative review we provide the reader with an introductory primer to the structure and function of esophageal perception, including nociception that forms the basis of the putative mechanisms that may give rise to symptoms in functional esophageal disorders. We also discuss the provocative techniques and outcome measures by which esophageal hypersensitivity can be established.

Entities:  

Mesh:

Year:  2017        PMID: 28005634     DOI: 10.1097/MCG.0000000000000757

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  11 in total

Review 1.  The role of oesophageal physiological testing in the assessment of noncardiac chest pain.

Authors:  Henriette Heinrich; Rami Sweis
Journal:  Ther Adv Chronic Dis       Date:  2018-09-11       Impact factor: 5.091

2.  Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease.

Authors:  T H Taft; J R Triggs; D A Carlson; L Guadagnoli; K N Tomasino; L Keefer; J E Pandolfino
Journal:  Aliment Pharmacol Ther       Date:  2018-03-12       Impact factor: 8.171

3.  Surgical management of gastroesophageal reflux disease in the obese patient.

Authors:  P Nau; H T Jackson; A Aryaie; A Ibele; D Shouhed; E Lo Menzo; M Kurian; L Khaitan
Journal:  Surg Endosc       Date:  2019-11-12       Impact factor: 4.584

4.  Effects of Osteopathic Visceral Treatment in Patients with Gastroesophageal Reflux: A Randomized Controlled Trial.

Authors:  Nuria Eguaras; Elena Sonsoles Rodríguez-López; Olga Lopez-Dicastillo; M Ángeles Franco-Sierra; François Ricard; Ángel Oliva-Pascual-Vaca
Journal:  J Clin Med       Date:  2019-10-19       Impact factor: 4.241

Review 5.  Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol.

Authors:  Dipesh H Vasant; Peter J Whorwell
Journal:  Neurogastroenterol Motil       Date:  2019-02-27       Impact factor: 3.598

6.  Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation.

Authors:  Andrea Oliveira Batista; Weslania Viviane Nascimento; Rachel Aguiar Cassiani; Ana Cristina Viana Silva; Leda Maria Tavares Alves; Dauana Cássia Alves; Roberto Oliveira Dantas
Journal:  Clinics (Sao Paulo)       Date:  2020-01-24       Impact factor: 2.365

Review 7.  Schwann Cells in Digestive System Disorders.

Authors:  Karina Goluba; Liga Kunrade; Una Riekstina; Vadims Parfejevs
Journal:  Cells       Date:  2022-02-28       Impact factor: 6.600

8.  Can Acute Stress Cause Esophageal Hypersensitivity in Healthy Individuals?

Authors:  Yu Kyung Cho
Journal:  J Neurogastroenterol Motil       Date:  2017-10-30       Impact factor: 4.924

Review 9.  Diagnosis and Management of Functional Chest Pain in the Rome IV Era.

Authors:  Ronnie Fass; Fahmi Shibli; Jose Tawil
Journal:  J Neurogastroenterol Motil       Date:  2019-10-30       Impact factor: 4.924

10.  Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders.

Authors:  Yan-Jun Wang; Xiu-Qiong Lang; Dan Wu; Yu-Qin He; Chun-Hui Lan; Xiao Xiao; Bin Wang; Duo-Wu Zou; Ji-Min Wu; Yong-Bin Zhao; Peter W Dettmar; Dong-Feng Chen; Min Yang
Journal:  J Neurogastroenterol Motil       Date:  2020-01-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.